Researchers from IDIBELL and the UB create a cell-by-cell map of the pancreas ducts and identify 15 new cell populations in the pancreas. THe results will provide a better understanding of how pancreatic cancer develops and will help find treatments for diabetes.
According to the study published in Nature Communications, the use of multiple quantitative PCR increased etiological diagnoses and reduced the time needed to achieve them, decreasing too the time to conversion from intravenous to oral treatment, although no reduction in antibiotic consumption was observed.
The donation made by the bride and groom and the guests will help fund the research led by Dr. Sonia Pernas, researcher at IDIBELL and ICO
The study, which has been published in the scientific journal ‘Journal of Experimental & Clinical Cancer Research’, shows that the ITGAV protein allows a better stratification of patients and reveals new therapeutic avenues for this carcinoma.
The purchase of the equipment has been financed by the Carlos III Health Institute (IFEQ22 call).
The research carried out by IDIBELL and Bellvitge University Hospital has found a higher level of antibiotic resistance in parainfluenzae than H. influenzae.
A new genomic study analyzes antibiotic resistance in two species of pathogenic bacteria Read More »
The grant will fund research on respiratory infections, the Antibiotic Use Optimization Program (PROA) incorporating a “One Health” perspective.
The cause is a change in the epigenetic pattern of the beta cells of the pancreas, which overexpress oncogenes and genes related to insulin production, thus altering their functioning.
A study describes how insulinomas, a rare type of pancreatic beta cell tumour, form Read More »
Neoadjuvant chemotherapy in breast cancer facilitates surgery and offers prognostic value. The 10-year survival rate is 84%, and 96% of patients who have a complete response to chemotherapy do not metastasize.
Researchers from IDIBELL and ICO have developed a bioinformatics algorithm that will improve the diagnosis of two cancer predisposition syndromes. This technique will speed up the diagnosis process and therapeutic decision-making in patients with suspected hereditary cancer.
